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Abstract
Background: There is little information about the possible influence of lifestyle
and etiologic risk factors on survival amongst patients with gastric cancer. 
Methods: We recruited a consecutive series of 249 patients with definite diagnosis
of gastric cancer who had been hospitalized in Towhid Hospital, Sanandaj, Kurdistan
Province in Western Iran during a five-year period from 2006 until 2011. Survival rate
was calculated according to the Kaplan-Meier and log rank statistical methods. Cox
hazard regression was used to investigate the effect of the variables and adjust for the
effect of age.
Results: According to univariate analysis, related variables that included age,
gender, Residence, histology grade, histology type, familial history of gastrointestinal
cancer and mental illness during the disease had no significant effects on survival rate
variation. Significant independent factors on survival included past medical history of
gastrointestinal diseases (P-value = 0.010), tobacco smoking (P-value = 0.012), and
early diagnosis (P-value = 0.008). Cox-regression analysis of demographic, lifestyle
and histological factors with >45 years of age as the reference revealed that patients
46-65 years of age at diagnosis (HR=0.602; 95% CI=0.250-1.44; P=0.256) and those
>66 years of age (HR=1.07, 95% CI=0.46-2.50, P≤0.001) had an increased risk for
disease progression and death. 
Conclusions: Past medical history of gastrointestinal diseases, tobacco smoking and
early stage diagnosis might influence the long-term survival of patients with gastric
cancer.
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Introduction
According to the World Health Organization
(WHO), the worldwide incidence of cancer was
10.5 million in 2000 and it will be 30 million by
2020.1 Currently, more than 25 million people
are living with cancer. Over the next decades,
cancers will considerably affect the global burden
of disease.2
Gastric cancer is one of the leading causes of
cancer-related deaths throughout the world.3,4
The effects of cancer are considerably higher than
the estimated number of patients and this figure
is increasing.5 Gastrointestinal cancers are the
fourth most common cancer after lung, breast
and colon, but it is still the second leading cause
for cancer deaths.6 According to the Iranian Cancer
Research Center, gastric cancer is the most
common cancer among men and the third most
common cancer in women following breast and
colon cancers.7 Geographic variations in Iran
show that the incidence and mortality of gastric
cancer is higher in the West and Northwest
regions, particularly in Kurdistan Province.8,9
Unlike the intestinal type which is decreasing the
diffuse type of gastric cancer is increasing which
has led to a decline in the incidence rate and an
annual increase in mortality rate.10
Gastric cancer survivors have been studied in
multiple series with patients stratified according
to disease stage, tumor type, tumor location and
type of therapy. An association between survival
and cancer stage was shown frequently.
Improvements in the five-year survival rate have
been reported over the past several decades.11 In
2007, the one- and five-year survival rates in
patients with upper gastrointestinal cancer in
Ardabil Province were reported as 40.5% (one-
year) and 0.8% (five-year).12
Considering the importance of the survival
rate estimation after diagnosis, the present study
aimed to evaluate the potential prognostic factors
that possibly affected gastric cancer patient
survival during the period 2006-2011.
Materials and Methods
Patients and methods
Data were sourced mainly from the patient
reports of pathology laboratories and hospital
database records. This was a concurrent
(prospective) study that used the census method
to locate all eligible patients diagnosed with upper
gastrointestinal cancers (249 gastric cancers) who
had been hospitalized at Towhid Hospital,
Sanandaj, Kurdistan Province in Western Iran.
Inclusion criteria included those with definite
diagnosis of upper gastrointestinal cancer during
Table 1. Demographic and histological characteristics of gastric
cancer patients.
Factors No. of
patients (%)
Age (years)
Under 45 9 (3.8)
45 to 65 90 (37.7)
Above 65 139 (58.8)
Sex
Male 178 (74.5)
Female 61 (25.5)
Residence
City 120 (50.2)
Village 119 (49.8)
Histology type
Intestinal type 145 (60.6)
Diffuse type 36 (15)
Unknown 58 (24.4)
Histology grade
Poorly differentiated 28 (33.3)
Moderately differentiated 25 (29.7)
Well differentiated 31 (36.9)
Stage of disease
Stages 2-3 142 (92.8)
Stage 1 25 (7.2)
Past medical history of 
gastrointestinal diseases
Yes 49 (24.6)
No 153 (76.4)
Family history of gastric cancer in 
first-degree relatives
Yes 87 (43)
No 115 (76.6)
Smoking status
Yes 103 (50.9)
No 99 (49.1)
Lack of psychiatric illness during treatment
Yes 34 (16.8)
No 168 (83.2)
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a five-year period from 2006 to 2011. Samples
were coded under the direct supervision of clinical
pathologists according to the International
Classification of Diseases for Oncology. Clinical
data such as practice treatment were obtained
through a structured questionnaire and the patients’
clinical records.  Vital status and date of death were
determined from patients' official death
certificates, with a maximum follow-up of 90
months. Survival time (in months) was calculated
from the date of diagnosis through the date of
death or last follow-up. Failure was defined as
death by any cause during the follow-up period
and patients alive at the end of the follow-up
period were censored. We excluded10 patients
from the analyses according to the following - 6
patients lost to follow-up; 2 had illegible data; and
2 patients emigrated. Overall, 239 patients with
gastric cancer were enrolled. Clinical and
pathologic variables, which were sub-layered into
age, gender, setting, histological type of tumor and
practice treatment were entered into parametric
Table 2. Median survival of gastric cancer patients.
Factors Median survival (by month)(95%CI) P-value
Gender 0.448
Male 11 (9.54-12.06)
Female 13 (11.46-14.86)
Age (years) 0.267
Under 45 12 (7.98-16.02)
46-65 12 (8.54-16.46)
Above 65 10 (8.71-11.29)
Residence 0.198
City 11 (9.47-12.53)
Village 10 (10.08-11.92)
Histological type 0.611
Intestinal 11 (9.82-12.18)
Diffuse 13 (11.21-14.79)
Other 10 (9.19-10.81)
Histology grade 0.309
Poorly differentiated 10 (7.06-12.94)
Moderately  differentiated 16 (13.94-18.06)
Well differentiated 13 (9.17-16.83)
Undifferentiated 11 (10.09-11.91)
Stage of disease 0.008
Stages 2-3 11 (9.55-13.35)
Stage 1 15 (13.77-16.94)
Past medical history of gastrointestinal diseases 0.003
Yes 9 (7.72-11.28)
No 12 (9.34-15.64)
Family history of gastric cancer in first-degree relatives 0.210
Yes 10 (7.72-13.28)
No 10 (7.90-13.10)
Smoking status 0.012
Yes 10 (8.78-11.22)
No 11 (8.98-12.02)
Lack of psychiatric illness during treatment 0.321
Yes 12 (8.90-15.10)
No 9 (6.48-15.52)
Type of treatment <0.001
Surgery 11 (4.42-19.57)
Chemotherapy 6 (3.92-6.07)
Radiotherapy 6 (2.91-7.09)
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regression models (by considering and not
considering heterogeneity) for multivariate
analysis in order to assess the relationships
between characteristics and prognostic factors
for survivors. The present study was approved
(Code no.: 91002; date: 22/08/2012) by the Ilam
University of Medical Sciences Ethics Committee
Results of the study eventually would be published
in general.
Statistical analysis
We used the Kaplan Meier method and log
rank statistics to compare survival rates in different
subgroups. Using a life table, survival rates and
survival density function was assessed at yearly
intervals. Breslow (generalized Wilcoxon)
statistics was used to compare median survival
time in three age groups. To investigate the effect
of the variables and adjust for the effect of age, we
used Cox hazards regression. Graphical methods
(diagram Log (S) t vs. time) and an analytical
method (time-varying covariate) were assessed to
appropriateness of Cox’s proportional hazard.13
P<0.05 was considered statistically significant.
Statistic analysis was performed using SPSS,
version.16
Results
We recruited 239 patients (74.5% males) with
gastric cancer. Mean age ± standard deviation
was 68.8 ± 11.97 years with a range of 37 to 97
years (Table 1). Overall, 49 (24.6%) had histories
of gastrointestinal disease and 87 (43%) had a
positive familial history of cancer. In general,
103 (50.9%) patients were smokers and 34
(16.8%) had histories of mental disorders. Based
on tumor type, 145 (60.6%) had intestinal type
histology and 36 (15.0%) had diffuse type tumors.
In univariate analysis, related variables that
included age, gender, Residence, histology grade,
histology type, familial history of gastrointestinal
cancer and mental illness during disease showed
no significant effects on survival rate variation.
Past medical history of gastrointestinal diseases
(P value = 0.010), tobacco smoking (P value =
0.012), and early diagnosis (P value = 0.008)
were significant independent factors for survival
(Table 2). 
We used Cox-regression analysis to predict
potential prognostic factors in patients with gastric
cancer. The model-building process takes place in
three blocks. In the first three blocks demographic
factors (age, gender, and setting) were added to the
analysis. Histological factors (histology grade,
histology type) comprised the second block,
whereas lifestyle factor (smoking status) and
disease history (family history of gastric cancer
among first-degree relatives, past medical history
of gastrointestinal disease) were in a three block
add in analysis. In cox regression if the step was
to add a variable, the inclusion makes sense if the
significance of the change is less than 0.05 and
remove a variable, if the significance of the change
is greater than 0.10. The final model included
age, histology grade and past medical history of
Table 3. Multivariate Cox regression analyses.
Cox-regression analysis for age, gender, setting, histology grade and tumor location
Characteristics . HR (95% CI) P value
Age (years) - Overall 0.016
Under 45 Reference 1 Reference
46-65 -0.508 0.602 (0.250-1.44) 0.256
Over 65 0.076 1.07 (0.46-2.50) 0.859
Histology grade - Overall 0.010
Poorly differentiated Reference 1 Reference
Moderately differentiated -1.25 0.285 (0.135-0.604) 0.001
Well differentiated -0.68 0.502 (0.26-0.95) 0.954
Past medical history of gastrointestinal disease - Overall 0.051
Yes Reference 1 Reference
No -0.413 0.662 (0.437-1.00) 0.051
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gastrointestinal disease. Cox-regression analysis
that used histological factors of >45 years of age
as the reference revealed that patients who were
46-65 years of age at diagnosis (HR=0.602, 95%
CI = 0.250-1.44, P=0.256) and >66years of age
(HR=1.07, 95% CI = 0.46-2.50, P≤0.001) had
increased risk for disease progression and death.
Cox-regression analysis for poor grade as the
reference showed that patients whose tumors were
moderately differentiated (HR=0.285, 95% CI =
0.135-0.604, P=0.001) and well differentiated
(HR=0.502, 95% CI = 0.26-0.95, P=0.954) had
decreased risk for death from Gastrointestinal
cancer (Table 3).
Kaplan-Meier analysis revealed significant
differences in five-year survival rate and smoking
status (log-rank=0.121; Figure 1A) and past
medical history of gastrointestinal disease (log-
rank=0.004; Figure 1B). The five-year survival
rates (by year) were 46%, 19.5%, 17%, 14% and
11.5% respectively. Overall five-year survival
among gastric cancer cases in the present study
was 11.5%. There were higher survival rates in
women (15.6%) compared to men (7.8%; P=0.48;
Table 4).
Discussion
Gastric cancer remains a major cause of cancer
mortality.6 During the last decades, the gastric
cancer mortality rate has decreased globally.14
However, this cancer remains a major public
health concern with a poor prognosis and high
Table 4. 1-5 year survival rates of gastric cancer according to demographic and histological factors.
Survival variables Survival rates (%) Median survival time (months)
1-year 2-year 3-year 4-year 5-year 
Gender Male 45.1 18.2 13.5 12.6 7.3 11.56
Female 48.2 21.3 19.7 15.6 15.6 11.90
Age (years)
Under 45 62.3 46.7 24.2 18.1 13.3 15.00
46-65 49.3 24.3 17.2 15.3 12.1 12.62
Over 65 43.4 17.1 14.2 11.3 8.5 11.08
Histological type
Intestinal 47.3 23.3 18.1 16.3 12.5 11.59
Diffuse 50.5 7.1 4.0 4.0 4.0 13.78
Figure 1. Survival functions in patients with gastric cancer according to Kaplan-Meier. (A) Smoking status. (B) Past medical history of
gastrointestinal disease. 
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mortality.1 In a recent review of survival analyses,
numerous studies have reported demographic,
clinical and pathologic characteristics of patients
by investigating variables related to survival.15-17
In this study, the effects of age, gender,
ResidenceS, tobacco smoking, histology grade,
histology type, familial history of gastrointestinal
cancer, mental illness during this disease, and
past medical history of gastrointestinal diseases on
survival time have been investigated. We found
that cancer management in Iran resulted in late
diagnosis which significantly reduced the five-year
survival rate of patients with gastric cancer.
Various studies have reported a number of
prognostic factors for gastric cancer.18,19 In our
study there was a significantly greater survival rate
among patients whose cancer was detected in the
early stages - a finding reported in several
corresponding studies.16,17,20 Other variable were
identified as independent prognostic factors for
patients with gastric cancer. In our results, gender
showed no impact on survival rate. However
some studies found a consistently lower survival
for women with gastric cancer.21 Smoking has
been determined to be a risk factor for numerous
cancers. As many as 14 types of cancers, including
gastric cancer, were found to be associated with
smoking in a cohort study of 34439 British doctors
over a number of years.22 Similar findings were
also found for patients with gastric cancer in
European countries. Smoking status was another
important prognostic factor for gastric cancer in
our study. This was similar to other studies where
patient survival was dependent on a positive
history of smoking.
Geographic variability in prognosis of gastric
cancer patients has been well documented.
Minimum and maximum survival rates have been
reported in European countries and East Asia,
respectively.14 Similarly, the five-year relative
survival rates for gastric cancer vary from 10% to
95% worldwide.21 In Iran the prognosis for
patients diagnosed with gastric cancers remains
poor. The five-year survival rate for 2006-2011
(the time of the present study) was 5.4%, which
was low. Mean age at diagnosis was 66.8 ± 11.97
years in the present study; the corresponding rate
in the Chinese population was 57.5 ± 10.9 years,17
which indicated a late diagnosis in the present
study. Gastric cancer has a male-to-female ratio
of approximately 2:119; in the present study we
reported a male-to-female ratio of 2.9:1. The
corresponding rate in the American population in
2009 was 1.54:1.14 
Although hospital series often provide more
optimistic data they are of limited value because
of unavoidable selection bias, in particular for
case selection and patient characteristics.
Conclusion
According to the results of this study, early
stage diagnosis significantly increases the five-year
survival rate in patients with gastric cancer. Thus
we recommend intervention for early detection and
therapy in the primary stage, which is necessary
to increase survival. Late diagnosis of gastric
cancer decreases the five-year survival rate which
seems to be the main difficulty in cancer
management in Iran. Surgery may be an effective
treatment for patients in this study. Smoking is
associated with decreased survival of patients
with gastric cancer.
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